As filed with the Securities and Exchange Commission on August 6, 2015

Registration No. 333-205907

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-1

REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933

 


 

Dermira, Inc.

(Exact name of Registrant as specified in its charter)

 


 

Delaware

 

2834

 

27-3267680

(State or other jurisdiction of
incorporation or organization)

 

(Primary Standard Industrial
Classification Code Number)

 

(I.R.S. Employer
Identification No.)

 


 

275 Middlefield Road, Suite 150

Menlo Park, California 94025

(650) 421-7200

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

 


 

Thomas G. Wiggans

Chief Executive Officer and Chairman of the Board

275 Middlefield Road, Suite 150

Menlo Park, California 94025

(650) 421-7200

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 


 

Please send copies of all communications to:

 

Douglas N. Cogen, Esq.

Michael A. Brown, Esq.

Robert A. Freedman, Esq.

Fenwick & West LLP

555 California Street, 12th Floor

San Francisco, California 94041

(415) 875-2300

Andrew L. Guggenhime

Chief Operating Officer and

Chief Financial Officer

275 Middlefield Road

Suite 150

Menlo Park, California 94025

(650) 421-7200

Andrew S. Williamson, Esq.

David G. Peinsipp, Esq.

Charles S. Kim, Esq.

Cooley LLP

101 California Street, 5th Floor

San Francisco, California 94111

(415) 693-2000

 

Approximate date of commencement of proposed sale to the public:  As soon as practicable after the effective date of this Registration Statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box.  o

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.    x 333-205907

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of ‘‘large accelerated filer,’’ ‘‘accelerated filer’’ and ‘‘smaller reporting company’’ in Rule 12b-2 of the Securities Exchange Act.  (Check one):

 

Large accelerated filer

o

 

Accelerated filer

o

Non-accelerated filer

x (Do not check if a smaller reporting company)

 

Smaller reporting company

o

 


 

This Registration Statement shall become effective upon filing in accordance with Rule 462(d) under the Securities Act.

 

 

 



 

EXPLANATORY NOTE AND INCORPORATION OF
CERTAIN INFORMATION BY REFERENCE

 

This Post-Effective Amendment No. 1 relates to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-205907), initially filed by the Registrant on July 28, 2015 and declared effective by the Securities and Exchange Commission on August 5, 2015. The Registrant is filing this Post-Effective Amendment No. 1 pursuant to Rule 462(d) under the Securities Act of 1933, as amended, for the sole purpose of replacing Exhibits 5.1 and 23.2 to the Registration Statement. This Post-Effective Amendment No. 1 does not modify any provision of Part I or Part II of the Registration Statement other than replacing Exhibits 5.1 and 23.2 to the Registration Statement as contained in Item 16 of Part II as set forth below.

 



 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 16. Exhibits and Financial Statement Schedules.

 

(a)              Exhibits

 

Exhibit
Number

 

Description

5.1

 

 

Opinion of Fenwick & West LLP.

23.2

 

 

Consent of Fenwick & West LLP (included in Exhibit 5.1).

24.1

 

 

Power of Attorney (included in the Registrant’s Registration Statement on Form S-1 (File No. 333-205907) filed with the Securities and Exchange Commission on July 28, 2015).

 

II-1



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Menlo Park, State of California, on this 6th day of August 2015.

 

 

DERMIRA, INC.

 

 

 

 

 

By:

/s/ Thomas G. Wiggans

 

 

Thomas G. Wiggans

 

 

Chief Executive Officer and Chairman of the Board

 

Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Thomas G. Wiggans

 

Chief Executive Officer and Chairman of the

 

August 6, 2015

Thomas G. Wiggans

 

Board (Principal Executive Officer)

 

 

 

 

 

 

 

 

 

Chief Operating Officer and Chief Financial

 

August 6, 2015

/s/ Andrew L. Guggenhime

 

Officer (Principal Financial Officer and Principal

 

 

Andrew L. Guggenhime

 

Accounting Officer)

 

 

 

 

 

 

 

*

 

Chief Medical Officer and Director

 

August 6, 2015

Eugene A. Bauer

 

 

 

 

 

 

 

 

 

*

 

Director

 

August 6, 2015

David E. Cohen

 

 

 

 

 

 

 

 

 

*

 

Director

 

August 6, 2015

Fred B. Craves

 

 

 

 

 

 

 

 

 

*

 

Director

 

August 6, 2015

Matthew K. Fust

 

 

 

 

 

 

 

 

 

*

 

Director

 

August 6, 2015

Wende S. Hutton

 

 

 

 

 

 

 

 

 

*

 

Director

 

August 6, 2015

Mark D. McDade

 

 

 

 

 

 

 

 

 

*

 

Director

 

August 6, 2015

Jake R. Nunn

 

 

 

 

 

 

 

 

 

*

 

Director

 

August 6, 2015

William R. Ringo

 

 

 

 

 

 

 

 

 

* By: /s/ Andrew L. Guggenhime

 

Attorney-in-Fact

 

August 6, 2015

Andrew L. Guggenhime

 

 

 

 

 

II-2



 

EXHIBIT INDEX

 

Exhibit
Number

 

Description

5.1

 

 

Opinion of Fenwick & West LLP.

23.2

 

 

Consent of Fenwick & West LLP (included in Exhibit 5.1).

24.1

 

 

Power of Attorney (included in the Registrant’s Registration Statement on Form S-1 (File No. 333-205907) filed with the Securities and Exchange Commission on July 28, 2015).